Adcare Health System Lifted to “Neutral” at Zacks (ADK)
Adcare Health System (NYSE:ADK) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report released on Monday. The firm currently has a $5.10 target price on the stock. Zacks‘s price objective points to a potential upside of 3.03% from the company’s current price.
Shares of Adcare Health System (NYSE:ADK) remained flat at $4.95 during during mid-day trading trading on Monday. 34,173 shares of the company’s stock traded hands. Adcare Health System has a 52 week low of $3.62 and a 52 week high of $5.05. The stock has a 50-day moving average of $4.74 and a 200-day moving average of $4.3. The company’s market cap is $85.2 million.
Adcare Health System (NYSE:ADK) last released its earnings data on Monday, August 11th. The company reported ($0.11) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.07) by $0.04. Analysts expect that Adcare Health System will post $-0.34 EPS for the current fiscal year.
In other Adcare Health System news, major shareholder Anthony J. Cantone unloaded 198,123 shares of the company’s stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $4.96, for a total value of $982,690.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.
AdCare Health Systems, Inc (NYSE:ADK) is a developer, owner and manager of retirement communities, assisted living facilities, skilled nursing facilities and home health care services in the state of Ohio.
To view Zacks’ full report, visit Zacks’ official website.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.